Silva KC, Rosales MA, Biswas SK et al.
University of Campinas, Campinas, São Paulo, Brazil.
Diabetes 2009;58:1382–90.
[2] Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway.
Zheng Z, Chen H, Ke G et al.
Shanghai Jiaotong University, Shanghai, China.
Diabetes 2009;58:954–64.
Editor’s note: Studies of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers in human patients with diabetes have shown a reduced risk for renal complications of the disease and a trend towards retinal protection by inhibiting the renin–angiotensin system.